直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
    • AI + Finnegan
    • Appeals, Issues, and Legal Strategy
    • Diligence, Licensing, and Opinions
    • Global IP Enforcement, Litigation, and Trials
    • Patent Office Invalidation Proceedings
    • Prosecution and Portfolio Management
    • Trademark and Brand Management
    • AI, Electronics, and Information Technology
    • Chemicals, Industrials, and Materials
    • Communications
    • Consumer Goods and Services
    • Energy
    • Hospitality, Gaming, and Leisure
    • Life Sciences
    • Transportation and Logistics
  • Experience

Opinions and Counseling

About

Evaluate your IP assets through opinions and counseling.

We render hundreds of opinions a year ranging from a single opinion on a specific patent to providing long-term, ongoing counseling on complex patent portfolios or litigation. We routinely address patent validity, enforceability, freedom to operate (FTO), misuse, design-around issues, licensing potential, IP contract construction and enforcement, and export controls. We regularly partner with our clients’ legal, business, and technical staffs to identify the potential for risk and reward, from idea to revenue-generating portfolios.

In addition to transactional counseling, we routinely advise clients on prelitigation strategies. Our extensive litigation experience gives us firsthand insight into the various types of arguments opponents may raise. Combining our litigation and IP transactional experience allows us to help guide our clients to favorable settlements of disputes before or during litigation.

Contacts

Danny M. Awdeh
Partner
Washington, DC
+1 202 408 4353
Email
Adriana L. Burgy
Partner
Washington, DC
+1 202 408 4345
Email
Aaron J. Capron
Partner
Palo Alto, CA
+1 650 849 6680
Email
Daniel C. Cooley
Partner
Reston, VA
+1 571 203 2778
Email
Elizabeth D. Ferrill
Partner
Washington, DC
+1 202 408 4445
Email
C. Gregory Gramenopoulos
Partner
Washington, DC
+1 202 408 4263
Email
Dr. Dr. Jochen Herr, LL.M.
Partner
Munich
+49 89 83931 1240
Email
D. Brian Kacedon
Partner
Washington, DC
+1 202 408 4301
Email
Amanda K. Murphy, Ph.D.
Partner
London
+44 (0)20 7864 2814
Email
Gerson S. Panitch
Partner
Washington, DC
+1 202 408 4000
Email
Aaron L. Parker
Partner
Washington, DC
+1 202 408 4387
Email
William B. Raich, Ph.D.
Partner
Washington, DC
+1 202 408 4210
Email
Douglas A. Rettew
Partner
Washington, DC
+1 202 408 4161
Email
Anthony C. Tridico, Ph.D.
Partner
Washington, DC
+1 202 408 4173
Email
M. David Weingarten, Ph.D.
Partner
Atlanta, GA
+1 404 653 6457
Email
Danny M. Awdeh
Partner
Washington, DC
+1 202 408 4353
Email
Adriana L. Burgy
Partner
Washington, DC
+1 202 408 4345
Email
Aaron J. Capron
Partner
Palo Alto, CA
+1 650 849 6680
Email
Daniel C. Cooley
Partner
Reston, VA
+1 571 203 2778
Email
Elizabeth D. Ferrill
Partner
Washington, DC
+1 202 408 4445
Email
C. Gregory Gramenopoulos
Partner
Washington, DC
+1 202 408 4263
Email
Dr. Dr. Jochen Herr, LL.M.
Partner
Munich
+49 89 83931 1240
Email
D. Brian Kacedon
Partner
Washington, DC
+1 202 408 4301
Email
Amanda K. Murphy, Ph.D.
Partner
London
+44 (0)20 7864 2814
Email
Gerson S. Panitch
Partner
Washington, DC
+1 202 408 4000
Email
Aaron L. Parker
Partner
Washington, DC
+1 202 408 4387
Email
William B. Raich, Ph.D.
Partner
Washington, DC
+1 202 408 4210
Email
Douglas A. Rettew
Partner
Washington, DC
+1 202 408 4161
Email
Anthony C. Tridico, Ph.D.
Partner
Washington, DC
+1 202 408 4173
Email
M. David Weingarten, Ph.D.
Partner
Atlanta, GA
+1 404 653 6457
Email

Everyone in this practice

Experience

Advised a global investment firm on patent and life sciences regulatory aspects in respect of medicines for rare diseases and specialty care products*

Advised a global investment firm on patent and life sciences regulatory aspects in respect of medicines for rare diseases and specialty care products.

Advised a global life sciences company on (non-)infringement issues relating to a chemistry-related patent covering an anti-cancer drug for treating leukemias*

Advised a global life sciences company on (non-)infringement issues relating to a chemistry-related patent covering an anti-cancer drug for treating leukemias.

Advised a pulmonary drug delivery company on (non-)infringement issues relating to inhalers*

Advised a pulmonary drug delivery company on (non-)infringement issues relating to inhalers.

Advised a biopharmaceutical company on patents covering a well-known biologic medicine for treating multiple types of cancer*

Advised a biopharmaceutical company on patents covering a well-known biologic medicine for treating multiple types of cancer.

Advised a global healthcare company on supplementary protection certificate (SPC) protection covering a small molecule medicine for treating leukemia*

Advised a global healthcare company on supplementary protection certificate (SPC) protection covering a small molecule medicine for treating leukemia.

Advised a biotechnology company on patents covering a well-known biologic medicine for treating eye diseases*

Advised a biotechnology company on patents covering a well-known biologic medicine for treating eye diseases.

More

Insights

Federal Circuit IP Blog

Federal Circuit Reverses Eligibility of Software Claims Where Technical Improvements Were Not Reflected in Claims

April 15, 2026

Federal Circuit IP Blog

Federal Circuit Reverses Indefiniteness Ruling on Means-Plus-Function Claim

April 15, 2026

Webinar

When Machines Invent: Patenting Innovations in the Age of AI

July 15, 2025

Webinar

Books

Biosimilars Litigation and Client Counseling

June 17, 2024

Seminar

Mobility Innovation: Business & Patent Strategies for Driving Success

May 22, 2024

Tel Aviv

Webinar

IP Agreements: Structuring Indemnification and Limitation of Liability Provisions to Allocate Infringement Risk

January 11, 2024

Webinar

More

News

Award/Ranking

10 Finnegan Attorneys Named to the 2023 IAM Strategy 300 List

October 5, 2023

Commentary

Eligibility Bill Gives Attys Relief, Even With 'Squishy' Terms

June 28, 2023

Announcement

Aaron Capron Named a 2023 Top Intellectual Property Lawyer

May 17, 2023

Commentary

How I Made Partner: Finnegan's Danielle Duszczyszyn Shares Six Keys to Business Development Success

December 16, 2020

Press Release

Esther H. Lim Nominated as Candidate for President-Elect of the D.C. Bar

March 6, 2017

Media Mention

Best Practice Series: Women’s Initiatives

March 17, 2015

More

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP